TechDogs-"Autonomize AI Raises $28 Million Series A To Power Next-Generation Agentic AI For Healthcare And Life Sciences"

Health Care Technology

Autonomize AI Raises $28 Million Series A To Power Next-Generation Agentic AI For Healthcare And Life Sciences

Business Wire
Overall Rating

With backing from new investors Valtruis, The Cigna Group Ventures, and Tau Ventures, Autonomize AI Scales the Only Proven Agentic AI Platform for Regulated Healthcare Workflows

AUSTIN, Texas--(BUSINESS WIRE)--Autonomize AI, a pioneer in AI-driven healthcare solutions, today announced that it raised $28 million in Series A funding, bringing total capital raised to $32 million to date. The round was led by Valtruis, The Cigna Group Ventures, Tau Ventures, and other strategic investors. Asset Management Ventures, ATX Venture Partners and Capital Factory are among the company’s existing investors who also participated.

The funding will be used to fuel the company’s mission to rewire healthcare operations with its Agentic AI Orchestration platform, enabling healthcare knowledge workers to focus on delivering better patient care by reducing the administrative burden that drives cost, clinician burnout, and fragmented experiences.

“The current healthcare system is no longer suited for the way care is delivered today—and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unnecessary friction,” said Ganesh Padmanabhan, CEO of Autonomize AI. “Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is. This funding will help us scale our platform to solve some of the most frustrating, high-impact operational challenges in healthcare, while keeping patients and care outcomes at the center.”

Autonomize AI stands apart with a platform purpose-built for the realities of healthcare. Its pre-trained, ready-to-deploy AI agents handle some of the industry’s most demanding workflows—like care management, utilization management, and benefits checks to chart reviews. These agents work together as intelligent Copilots in a coordinated, multi-agent system that understands real workflows, not just prompts. This isn’t generic Generative AI. It’s a healthcare-native orchestration platform already delivering real, measurable value at scale inside Fortune 100 healthcare enterprises.

“There’s never been a more important time to apply AI in healthcare,” said Mike Spadafore, Managing Director at Valtruis. “Healthcare operators are ready, but they need partners who understand real workflows and can deliver results at scale. That takes more than technical talent — it requires deep knowledge of how care is delivered and paid for. Autonomize AI gets that. Their platform enables healthcare operators to quickly deploy and scale AI agents across high-impact use cases — and they’re already driving real results at some of the country’s largest healthcare organizations. We’re excited for the opportunity to partner with them.”

Autonomize AI has already achieved transformative results, including:

  • 36,000 clinical hours saved per month that was spent on mundane administrative tasks;
  • 100,000+ automated care plans created monthly to free up care providers and case managers for higher-value patient interactions; and
  • Up to 50% faster decisions for patients in prior authorizations and claims.

Unlike narrow solutions from generic AI platforms, Autonomize AI offers enterprise-wide orchestration and explainability to meet the complex needs of regulated healthcare environments with built-in transparency, human-in-the-loop workflows, and industry leading accuracy.

“Autonomize AI’s vision for augmenting, not replacing, the people who power healthcare is one we share,” said Craig Cimini, Head of The Cigna Group Ventures. “We see tremendous potential in the company’s platform to drive scalable, responsible innovation in healthcare operations while ensuring patients and providers remain at the center of care.”

Autonomize AI was founded in 2022 by Ganesh Padmanabhan and Kris Nair, with a goal to make healthcare more accessible, efficient and patient-centered with AI. The company is one of the few that has seen strong traction in multiple segments in healthcare and life sciences, delivering both patient impact and proven value at scale by solving real operational challenges.

About Autonomize AI

Autonomize’s AI copilots organize, contextualize and summarize unstructured data to reduce the administrative burden for healthcare knowledge workers to make data-driven decisions and improve patient outcomes. Their customers include Top 20 Pharmaceuticals, Fortune 100 Healthcare Enterprises, and Life Sciences companies.


Contacts

PR Contact
Avenue Z
autonomize@avenuez.com

Frequently Asked Questions

What is Autonomize AI?

Autonomize AI is a company that provides an Agentic AI Orchestration platform designed to streamline healthcare operations and improve patient outcomes by automating administrative tasks.

What problems does Autonomize AI solve?

Autonomize AI addresses challenges like clinician burnout, fragmented patient experiences, and high operational costs by automating workflows such as care management, utilization management, and benefits checks.

What are the benefits of using Autonomize AI?

The benefits include saving clinical hours, automating care plan creation, faster patient decisions, and improved data-driven decision-making for healthcare knowledge workers.

First published on Fri, Jun 13, 2025

Enjoyed what you've read so far? Great news - there's more to explore!

Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.

Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.

Dive into TechDogs' treasure trove today and Know Your World of technology!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Loading comments...

  • Dark
  • Light